IRCT20200428047228N1
Recruiting
Phase 3
Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19
Quality Improvement of Intensive Care Research Center- Shahid Beheshti University0 sites50 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Quality Improvement of Intensive Care Research Center- Shahid Beheshti University
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a\-Respiratory Rate(RR)\=30 /min
- •b\-SpO2\<93% on room air
- •c\-PaO2/FIO2\<300
- •d\-CT scan Involvement\>50%
- •e\-Diagnosis confirmed by CPR or CT scan
- •f\-Age more than 18 years
Exclusion Criteria
- •a\-G6PD Deficiency
- •b\-QT interval more than 450 milliseconds
- •c\-myasthenia gravis
- •d\-Pregnancy\- Breast Feeding
- •e\-Severe Renal or Hepatic Failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19COVID-19.COVID-19U07.1IRCT20150808023559N23Ardabil University of Medical Sciences100
Completed
N/A
Investigation on the efficacy and safety of favipiravir in patients who are infected or strongly suspected of being infected with Ebola virusEbola virus diseaseJPRN-UMIN000016101ational Center for Global Health and Medicine5
Active, Not Recruiting
Phase 1
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without PneumoniaCOVID-19 Patients without PneumoniaTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-005214-18-LTVilnius University Hospital Santaros klinikos75
Active, Not Recruiting
Phase 1
Clinical trial of Favipiravir treatment of patients with COVID-19EUCTR2020-002728-35-HUHungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium150
Active, Not Recruiting
Phase 1
An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild PneumoniaCOVID-19 Patients with Mild PneumoniaTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-005128-12-LTVilnius University Hospital Santaros klinikos96